Details of the Drug Formulaction

General Information of Drug Formulation (ID: F22133)

• Formulation Name: Vandetanib 300 mg tablet
• Company: AstraZeneca

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Vandetanib	(DMRICNP)	Solid tumour/cancer	2A00-2F9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Brushite	(E00392)	104805	Diluent
Crospovidone	(E00626)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 300	(E00651)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent